Viewing nowNew Shubatine Tablet 10mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Anguk New Pharm Co., Ltd.

MFDS item code 201802674 · Approved 2018.06.27 · Insurance code 053600780
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is primarily used as an adjunct in patients with hypercholesterolemia and combined hyperlipidemia for whom dietary changes and exercise are insufficient. It is also used as an adjunct to diet or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. This drug lowers total cholesterol and LDL-cholesterol levels, delaying the progression of atherosclerosis, and improves cholesterol levels in pediatric patients aged 10 to 17 who meet certain criteria for heterozygous familial hypercholesterolemia. It is also effective as a dietary adjunct in patients with primary dysbetalipoproteinemia. Additionally, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in men aged 50 and older and women aged 60 and older with specific cardiovascular risk factors. Thus, it is effectively used in reducing the risk of cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Older adults : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Aged 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, it should not be administered to patients with allergies to its components, severely impaired liver function, muscle disorders, severely compromised kidney function, or women who are pregnant or breastfeeding. Additionally, this medication may affect muscle tissue, potentially leading to symptoms such as muscle pain or myopathy; thus, elderly patients or those with a history of muscle disorders or heavy alcohol consumption should use it cautiously. If symptoms such as muscle pain, muscle weakness, or cramps occur during treatment, consultation with a doctor should be sought immediately. Since liver function abnormalities may occur, it is important to perform regular liver function tests before starting and during treatment. If symptoms of liver damage (such as jaundice, severe fatigue, etc.) occur, treatment should be discontinued immediately. This medication may interact with other drugs, so patients taking other medications should inform their doctor or pharmacist. Particularly, combining this medication with specific antiviral agents, immunosuppressants, some antibiotics, and fibrates may increase the risk of muscle disease. Women of childbearing potential should use appropriate contraception while taking this medication and should not use it during pregnancy. It is also advisable to avoid this drug while breastfeeding. There is no specific antidote in cases of overdose; treatment according to symptoms and liver function and muscle enzyme testing is required. Finally, this medication may cause symptoms like dizziness, so caution is advised when driving or operating machinery.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, erythema multiforme drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and is best kept at room temperature between 1 degree and 30 degrees Celsius. It can be safely used for 36 months from the date of manufacture.
Pink round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Anguk New Pharm Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.